Glenmark's cut-price Seretide generic to debut in Russia
This article was originally published in Scrip
Executive Summary
Glenmark Pharmaceuticals is set to introduce its generic version of GlaxoSmithKline's blockbuster asthma/COPD product Advair/Seretide (salmeterol/fluticasone) in Russia marking its entry into the respiratory space there.